CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net loss	$ (350,681,000)	$ (88,937,000)	$ (116,713,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	16,054,000	2,313,000	4,037,000
Stock-based compensation	33,145,000	27,931,000	28,792,000
Loss on change in fair value of ELOC program	0	1,901,000	1,075,000
Change in fair value of derivative and warrant liability	0	0	606,000
Amortization of debt issuance cost	1,621,000	5,400,000	2,287,000
Non-cash lease amortization	2,613,000	3,346,000	3,189,000
Loss on early extinguishment of debt	15,629,000	837,000	0
Foreign currency gain/loss from remeasurement	(24,000)	143,000	0
Change in fair value of contingent acquisition liabilities	222,670,000	0	0
Deferred income taxes	(12,183,000)	30,000	2,127,000
Other, net	(580,000)	93,000	0
Changes in operating assets and liabilities:
Accounts receivable, net	(10,264,000)	(627,000)	(1,354,000)
Prepaid expenses	0	1,590,000	(1,238,000)
Other current assets	(3,131,000)	(821,000)	299,000
Contract assets	(7,304,000)	(19,578,000)	(8,658,000)
Other non-current assets	(196,000)	671,000	(274,000)
Accounts payable	(7,636,000)	(1,162,000)	302,000
Accrued liabilities	1,846,000	4,266,000	116,000
Other current liabilities	(642,000)	0	0
Operating lease liabilities	(3,214,000)	(3,657,000)	(3,912,000)
Deferred revenue	(6,186,000)	(4,135,000)	(7,646,000)
Other non-current liabilities	(415,000)	2,131,000	2,946,000
Net cash used in operating activities	(108,878,000)	(68,265,000)	(94,019,000)
Cash flows from investing activities:
Purchases of property and equipment	(640,000)	(392,000)	(1,329,000)
Payment related to acquisitions, net of cash acquired	(11,732,000)	0	0
Net cash used in investing activities	(12,372,000)	(392,000)	(1,329,000)
Cash flows from financing activities:
Proceeds from the issuance of Series A Preferred Stock, net of issuance costs	0	24,942,000	0
Proceeds from sales of Class A common stock under the ELOC program, net of issuance costs	0	71,615,000	0
Proceeds from sales of Class A common stock under the Sales Agreement, Equity Distribution Agreement and Execute Equity Distribution Agreement	407,270,000	12,412,000	0
Proceeds from exercise of stock options and employee stock purchase plan	29,685,000	0	0
Proceeds from warrants exercised	23,000	0	0
Payment of financing costs associated with the Sales Agreement, Equity Distribution Agreement and Execute Equity Distribution Agreement	(10,357,000)	0	0
Proceeds from the issuance of debt, net of issuance costs	0	85,087,000	0
Proceeds from the issuance of common stock	0	9,369,000	4,160,000
Proceeds from Business Combination and PIPE, net of transaction costs	0	0	90,689,000
Payments on notes payable	(215,373,000)	(35,029,000)	(11,545,000)
Payment to settle contingent holdback liabilities from SYNQ3 and other acquisitions	(217,000)	0	0
Payments on finance leases	(125,000)	(159,000)	(1,303,000)
Net cash provided by financing activities	210,906,000	168,237,000	82,001,000
Effects of exchange rate changes on cash	225,000	(20,000)	0
Net change in cash, cash equivalents, and restricted cash equivalents	89,881,000	99,560,000	(13,347,000)
Cash, cash equivalents, and restricted cash equivalents, beginning of year	109,035,000	9,475,000	22,822,000
Cash, cash equivalents, and restricted cash equivalents, end of year	198,916,000	109,035,000	9,475,000
Reconciliation to amounts on the consolidated balance sheets:
Cash and cash equivalents	198,240,000	95,260,000	9,245,000
Current portion of restricted cash equivalents	0	0	0
Non-current portion of restricted cash equivalents	676,000	13,775,000	230,000
Total cash, cash equivalents, and restricted cash equivalents shown in the consolidated statements of cash flows	198,916,000	109,035,000	9,475,000
Supplemental disclosures of cash flow information:
Cash paid for interest	6,337,000	11,984,000	4,364,000
Cash paid for income taxes	2,717,000	2,356,000	1,044,000
Noncash or Part Noncash Acquisitions [Line Items]
Debt discount through issuance of common stock warrants	0	4,136,000	0
Issuance of Class A Common Stock to settle obligations under Amelia Debt	11,817,000	0	0
Issuance of Class A Common Stock to settle contingent holdback consideration of SYNQ3 acquisition	189,000	0	0
Conversion of convertible note into common stock pursuant to Business Combination	0	0	20,239,000
Operating lease liabilities arising from obtaining right-of-use assets	1,559,000	0	650,000
Deferred offering costs reclassified to additional paid-in capital	220,000	0	0
Synq3, Inc
Noncash or Part Noncash Acquisitions [Line Items]
Fair value of common stock, deferred equity, earnout and holdback consideration under acquisitions	33,606,000	0	0
Synq3, Inc | Contingent earnout consideration
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of contingent acquisition liabilities	219,000,000.0
Noncash or Part Noncash Acquisitions [Line Items]
Fair value of common stock, deferred equity, earnout and holdback consideration under acquisitions	67,945,000	0	0
Synq3, Inc | Contingent Holdback Consideration
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of contingent acquisition liabilities	3,700,000
Noncash or Part Noncash Acquisitions [Line Items]
Fair value of common stock, deferred equity, earnout and holdback consideration under acquisitions	570,000	0	0
Other Acquisition
Noncash or Part Noncash Acquisitions [Line Items]
Fair value of deferred cash consideration under other acquisition	195,000	0	0
Settle Commitment Shares Related to the ELOC Program
Noncash or Part Noncash Acquisitions [Line Items]
Issuance of Class A Common Stock to settle commitment shares related to the ELOC program	0	915,000	0
Convertible preferred stock
Noncash or Part Noncash Acquisitions [Line Items]
Conversion of redeemable convertible preferred stock to common stock pursuant to Business Combination	14,187,000	10,755,000	0
Redeemable convertible preferred stock
Noncash or Part Noncash Acquisitions [Line Items]
Conversion of redeemable convertible preferred stock to common stock pursuant to Business Combination	$ 0	$ 0	$ 279,503,000